Conditions: Type 1 Diabetes (T1D); Metabolic Diseases; Glucose Metabolism Disorders; Endocrine System Diseases; Autoimmune Diseases; Immune System Diseases; Diabetes Melletus, Type 1; Nutritional and Metabolic Diseases; Combination Therapy
Interventions: Drug: AMX0035; Drug: Placebo
Sponsors: University of Washington; Breakthrough T1D
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.